ArticleVaccines2022

COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections.

Dejan Jakimovski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.